PELL Bio-Med Technology Co (TPE:6949) LT-Debt-to-Total-Asset: 0.05 (As of Dec. 2025)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$960.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co LT-Debt-to-Total-Asset?

PELL Bio-Med Technology Co TPE:6949 +4.35% 13 LT-Debt-to-Total-Asset is 0.05 as of Dec. 2025. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PELL Bio-Med Technology Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.05.

PELL Bio-Med Technology Co's long-term debt to total assets ratio declined from Dec. 2024 (0.08) to Dec. 2025 (0.05). It may suggest that PELL Bio-Med Technology Co is progressively becoming less dependent on debt to grow their business.

PELL Bio-Med Technology Co  (TPE:6949) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PELL Bio-Med Technology Co LT-Debt-to-Total-Asset Related Terms

PELL Bio-Med Technology Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co LT-Debt-to-Total-Asset Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
0.32 0.17 0.10 0.08 0.05

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.07 0.07 0.05
TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co LT-Debt-to-Total-Asset Calculation

PELL Bio-Med Technology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=109.278/2112.225
=0.05

PELL Bio-Med Technology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=109.278/2112.225
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.05 mean?
PELL Bio-Med Technology Co (TPE:6949) has a LT-Debt-to-Total-Asset of 0.05 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on PELL Bio-Med Technology Co and its competitors.
Is PELL Bio-Med Technology Co's LT-Debt-to-Total-Asset too high?
PELL Bio-Med Technology Co's current LT-Debt-to-Total-Asset is 0.05. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's LT-Debt-to-Total-Asset compare to VRTX and REGN?
PELL Bio-Med Technology Co's LT-Debt-to-Total-Asset of 0.05 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current LT-Debt-to-Total-Asset is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current LT-Debt-to-Total-Asset of 0.05. The current LT-Debt-to-Total-Asset is 0.05. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current LT-Debt-to-Total-Asset is 0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$960.00
Price